Assembly Biosciences, Inc. Accrued Liabilities, Current
Assembly Biosciences, Inc. (ASMB) had Accrued Liabilities, Current of $3.34 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $3.34M.
- 2026-03-31: Accrued Liabilities, Current $2.66M.
- 2025-12-31: Accrued Liabilities, Current $7.75M.
- 2025-09-30: Accrued Liabilities, Current $5.73M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $3.34M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.66M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $7.75M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $5.73M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.41M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $2.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.86M 10-K · filed 2026-03-19 |
| 2024-09-30 | $4.76M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.59M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.05M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $5.74M 10-K · filed 2025-03-20 |
| 2023-09-30 | $3.89M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.19M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.15M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $7.32M 10-K · filed 2024-03-28 |
| 2022-09-30 | $5.69M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.75M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $6.86M 10-K · filed 2023-03-22 |
| 2021-09-30 | $5.46M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.32M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.66M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $11.99M 10-K · filed 2022-03-11 |
| 2020-09-30 | $7.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.02M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $4.43M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $8.29M 10-Q · filed 2020-11-05 |
| 2019-09-30 | $9.43M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $7.58M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $10.14M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $9.68M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $6.52M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $5.08M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $4.65M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $6.14M 10-K · filed 2019-02-28 |
| 2017-09-30 | $6.35M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $6.31M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.01M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $4.75M 10-K · filed 2018-03-08 |
| 2016-09-30 | $3.64M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.63M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.24M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $2.04M 10-K · filed 2017-03-02 |
| 2015-09-30 | $1.19M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $935.66K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $877.54K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $146.42K 10-K · filed 2016-03-11 |
| 2014-06-30 | $48.44K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $27.25K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $23.43K 10-K · filed 2015-03-16 |
| 2013-09-30 | $37.41K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $453.71K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $449.44K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $898.21K 10-K · filed 2014-03-31 |
| 2012-09-30 | $838.10K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $234.00K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $710.00K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $171.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |